EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Checkpoint Dilemma: KEYNOTE-564’s Triumph Amidst the Failures of Its Rivals in Renal Cell Carcinoma?

Akhil Santhosh, Nihanthy Sreenath

Journal of Case Reports and Reviews in Medicine · 2025

DOI: 10.64978/jcrrm-0115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Case Reports and Reviews in Medicine, 2025. Verfasst von Akhil Santhosh und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Santhosh, A., & Sreenath, N. (2025). Checkpoint Dilemma: KEYNOTE-564’s Triumph Amidst the Failures of Its Rivals in Renal Cell Carcinoma?. Journal of Case Reports and Reviews in Medicine. https://doi.org/10.64978/jcrrm-0115

Vancouver

Santhosh A, Sreenath N. Checkpoint Dilemma: KEYNOTE-564’s Triumph Amidst the Failures of Its Rivals in Renal Cell Carcinoma?. Journal of Case Reports and Reviews in Medicine. 2025. doi:10.64978/jcrrm-0115

BibTeX
@article{Santhosh2025,
  author = {Santhosh, Akhil and Sreenath, Nihanthy},
  title = {Checkpoint Dilemma: KEYNOTE-564’s Triumph Amidst the Failures of Its Rivals in Renal Cell Carcinoma?},
  journal = {Journal of Case Reports and Reviews in Medicine},
  year = {2025},
  doi = {10.64978/jcrrm-0115}
}
Kostenlos starten →